The Anti-Cancer Mechanism of Cyclin D1-Ablative Drug on Breast Cancer
碩士 === 國立中山大學 === 生物醫學研究所 === 96 === Breast cancer is the fifth most common cause of cancer death in the worldwide. In the past decades, tamoxifen has been used for clinical treatment for breast cancers. The derivatives of compound thiazolidinedione (TZDs) including troglitazone (rezulin) and rosigl...
| Main Authors: | , |
|---|---|
| Other Authors: | |
| Format: | Others |
| Language: | en_US |
| Published: |
2008
|
| Online Access: | http://ndltd.ncl.edu.tw/handle/tdxjrt |